
Manus Neurodynamica provides a handheld diagnostic system that detects and quantifies fine motor abnormalities to support earlier diagnosis and monitoring of Parkinson’s and other neuromotor disorders. Its NeuroMotor Pen is a non-invasive, patented medical device with built-in motion sensors and analytical software that uses AI and cloud analytics to convert minute limb and hand movements into clinically validated biomarkers. The company sells via a B2B SaaS and licensing model to clinicians, general practitioners, and specialist services and integrates into clinical workflows to streamline referrals and reduce reliance on brain imaging. The technology targets digital health and medtech markets across primary care, specialist neurology, rehabilitation, and drug development applications.

Manus Neurodynamica provides a handheld diagnostic system that detects and quantifies fine motor abnormalities to support earlier diagnosis and monitoring of Parkinson’s and other neuromotor disorders. Its NeuroMotor Pen is a non-invasive, patented medical device with built-in motion sensors and analytical software that uses AI and cloud analytics to convert minute limb and hand movements into clinically validated biomarkers. The company sells via a B2B SaaS and licensing model to clinicians, general practitioners, and specialist services and integrates into clinical workflows to streamline referrals and reduce reliance on brain imaging. The technology targets digital health and medtech markets across primary care, specialist neurology, rehabilitation, and drug development applications.